ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 408171 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 408171; 2) Community: the network communities that were significantly associated with the response to NSC 408171; 3) Molecule: the relationships between components within communities and NSC 408171; 4) MDR: the compounds that were significantly associated with the NSC 408171.

NSC Compound Enrichment Correlation
NSC 666355 Null 0.0430505868034761 0.61217251
NSC 670284 Null 0.0430505868034761 -0.31754553
NSC 671134 Null 0.0430505868034761 0.12892228
NSC 675254 Null 0.0430505868034761 0.14269707
NSC 67586 2-Naphthacenecarboxamide, N-[[(6,7-dihydro-7-oxo-1H-1,2,3-triazolo[4,5-d]pyrimidin-5-yl)amino]methyl]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, 0.0430505868034761 -0.072033045
NSC 6777 Null 0.0430505868034761 0.31298153
NSC 680094 17-(O-Diethylaminoethyl)oximino-3-methoxy-1,3,5(10)- estratriene hydrochloride 0.0430505868034761 -0.19147057
NSC 681643 Camptothecin Derivative 0.0430505868034761 0.11650754
NSC 681646 Camptothecin Derivative 0.0430505868034761 -0.0025571901
NSC 682768 Null 0.0430505868034761 0.50289228
Total:76  Current:66    [First] [Prev] [Next] [Last]